Umbilical artery velocity waveforms: normal reference values for A/B ratio and Pourcelot ratio

Safety of a physical therapy protocol for women with preeclampsia: a randomized controlled feasibility trial

OBJECTIVE

To assess the feasibility and safety of a physiotherapy protocol applied to pregnant women with preeclampsia.

METHODS

Randomized, controlled, single-blind feasibility study, with 24 hospitalized pregnant women with preeclampsia. The intervention group received one session of the physiotherapy. The control group remained under the routine care of the hospital. The primary outcomes were Doppler velocimetry, cardiotocography, and maternal-fetal hemodynamics. Secondary outcomes were pain and anxiety assessed before and after the interventions. A mixed effects linear regression model was used, and the data were compared with the level of significance at 5%.

RESULTS

The baseline characteristics of the participants were homogeneous between groups. Resistance index of the Middle Cerebral Artery (MAC) and Umbilical Artery (UA) and cardiotocography did not change significantly. The systolic blood pressure (SBP) increased 4.90 mmHg in the control group and 0.22 mmHg in the intervention group. The diastolic blood pressure (DBP) increased 1.34 mmHg in the control group and decreased 0.40 mmHg in the intervention group. The middle bood pressure (MBP) increased 4.66 mmHg in the control group while there was a decrease of 0.09 mmHg in the intervention group, without statistical difference. Heart rate (HR) decreased 0.94 bpm in the control group; whereas, in the intervention group, there was an increase of 6.30 bpm. The pain reduced clinically 2 points after the intervention. The anxiety reduced clinically in both the groups (-1.26 in the intervention group and -2.17 in the control group).

CONCLUSION

The protocol applied in the intervention group is feasible and safe for both mother and fetus. Both groups showed clinical reduction in the levels of anxiety; whereas, pain was clinically reduced in the intervention group.

Reference ranges for ductus venosus velocity ratios in pregnancies with normal outcomes

OBJECTIVES

The purpose of this study was to establish reference ranges for ductus venosus velocity ratios.

METHODS

Singleton pregnancies from 11 to 38 weeks with exactly established gestational ages (GAs) were recruited for the study. Pregnancies with fetal anomalies, growth abnormalities, maternal medical complications, stillbirth, birth weight below the 10th or above the 90th percentile, and neonatal anomalies were excluded. The ductus venosus pulsatility index for veins (PIV) and velocity ratios (S/v, S/D, v/D, S/a, v/a, and D/a, where S indicates ventricular systole [s-wave], v, ventricular end-systolic relaxation [v-descent], D, passive diastolic ventricular filling [D-wave], and a, active ventricular filling during atrial systole [a-wave]) were calculated. Separate regression models were fitted to estimate the mean and standard deviation at each GA for each ratio.

RESULTS

A total of 902 velocity wave ratios and ductus venosus PIVs were used for reference ranges. The S/v, S/D, and v/D ratios were not changed with GA (P > .05 for all). The PIV and S/a, v/a, and D/a ratios were reduced with GA (P < .0001 for all). Significant reductions in the means and standard deviations of the PIV and S/a, v/a, and D/a ratios were observed between 17 and 18 weeks' gestation. Therefore, nomograms were separately created between 11 and 17 weeks and 18 and 38 weeks.

CONCLUSIONS

We created reference ranges for ductus venosus velocity ratios between 11 and 38 weeks' gestation in normal pregnancies. These reference ranges may prove beneficial for evaluation of fetal conditions that are associated with cardiovascular abnormalities.

Effect of maternal asthma, inhaled glucocorticoids and cigarette use during pregnancy on the newborn insulin-like growth factor axis

BACKGROUND

Fetal growth varies in a sex-specific manner in response to maternal asthma during pregnancy, but the mechanisms are unclear.

OBJECTIVE

We examined the influence of maternal asthma severity and associated exposures, inhaled glucocorticoid treatment, maternal cigarette use, and fetal sex on fetal growth and placental function during pregnancy and on the newborn insulin-like growth factor (IGF) axis. STUDY SUBJECTS AND DESIGN: Fetal growth was assessed in a prospective cohort of asthmatic and non-asthmatic women (n=145). At delivery, umbilical vein plasma was collected from male (n=61, controls n=16 and asthmatic n=45) or female (n=84, controls n=22 and asthmatic n=62) fetuses. Cord plasma insulin-like growth factor (IGF) binding protein (BP)-1, IGFBP-3, IGF-1 and IGF-2 were measured by radioimmunoassay and ELISA.

RESULTS

Cord plasma IGF-1 was the main component of the neonatal IGF axis altered by asthma and cigarette use. IGF-1 was increased in the presence of mild asthma and a male fetus and decreased in the presence of a female fetus and maternal asthma with cigarette use. IGFBP-3 was also decreased in the female fetuses of pregnancies complicated by asthma and cigarette use. Inhaled glucocorticoid use for the treatment of asthma did not affect the IGF axis. The strongest overall predictor of female birth weight after accounting for asthma severity, inhaled glucocorticoid treatment and cigarette use was IGF-1. For males, the strongest predictor of birth weight was IGFBP-3.

CONCLUSION

The data suggest male and female fetuses institute different strategies in response to adverse pregnancy conditions such as asthma and cigarette use.

Comparison of the intrapartum analysis of Doppler blood flow velocity waveform of the umbilical artery and fetal heart rate tracing for the prediction of perinatal outcome

This study was performed to determine the value of umbilical artery Doppler flow velocity waveform (FVW) analysis and fetal heart rate (FHR) tracing in the course of labour for predicting poor perinatal outcome. The randomised, controlled and prospective study was carried out on 99 singleton term pregnant women in labour at the Zeynep Kamil Women and Children's Hospital, Istanbul. All patients were evaluated by both methods during the intrapartum period. Blood gases and pH of umbilical venous blood and 1 and 5 minute Apgar scores of the newborn infants were determined immediately after delivery. For the prediction of poor perinatal outcome, the sensitivity, specificity, negative predictive value and positive predictive value of FHR were 72.0%, 85.1%, 60.1% and 90.0%, respectively. FHR was pathological in all four cases with a neonatal death, whereas only two had pathological Doppler FVW. We conclude that FHR is a more sensitive method than umbilical artery Doppler FVW analysis (72.0% versus 36.0%) in the prediction of poor perinatal outcome during the intrapartum period. A combination of the two tests increases the specificity of the prediction of poor perinatal outcome from 89.2% and 85.1% to 94.9%. High negative predictive values of both tests should reassure the clinician when the test results are normal.

Endostatin concentration in cord plasma predicts the development of bronchopulmonary dysplasia in very low birth weight infants

INTRODUCTION

Endostatin is an antiangiogenic growth factor. Together with proangiogenic growth factors it acts to shape the developing vasculature. Dysregulation of angiogenesis is a component in the pathogenesis of bronchopulmonary dysplasia.

OBJECTIVE

Our goal was to study whether the concentration of circulating endostatin at birth is associated with the development of bronchopulmonary dysplasia in very low birth weight infants.

PATIENTS AND METHODS

Endostatin concentration was measured in cord plasma from 92 very low birth weight infants (gestational age < 32 weeks; birth weight < 1500 g) and 48 healthy term infants (gestational age > 37 weeks; birth weight > 2500 g).

RESULTS

Endostatin concentration in very low birth weight infants was lower than in healthy term infants. Within the very low birth weight group no correlation existed between endostatin concentration and gestational age or relative birth weight. Very low birth weight infants who subsequently developed bronchopulmonary dysplasia had higher cord endostatin than those who did not. Higher endostatin concentration was associated with higher odds for bronchopulmonary dysplasia. Adjusted for gestational age, the odds for bronchopulmonary dysplasia were higher.

CONCLUSIONS

Circulating endostatin in term infants was higher than in very low birth weight infants, suggesting a temporal pattern for fetal endostatin concentration. In very low birth weight infants a high concentration of circulating endostatin at birth is associated with the subsequent development of bronchopulmonary dysplasia.

Increased expression of N-myc downstream-regulated gene 1 (NDRG1) in placentas from pregnancies complicated by intrauterine growth restriction or preeclampsia

OBJECTIVE

N-myc downstream-regulated gene 1 (NDRG1) modulates placental response to hypoxia. We therefore hypothesized that the expression of NDRG1 is altered in placentas from pregnancies complicated by intrauterine growth restriction (IUGR) or preeclampsia (PE), which are associated with fetoplacental underperfusion and cellular hypoxia.

STUDY DESIGN

Thirty-five pregnant women in the third trimester of pregnancy were recruited according to the following 3 groups: (1) normal term pregnancy (n = 10), (2) pregnancy complicated by IUGR (n = 9), and (3) pregnancy with severe PE (n = 16). Placental samples were collected after cesarean delivery without labor. NDRG1 was measured with the use of immunostaining, Western blot, and real-time quantitative polymerase chain reaction (RT-qPCR). Umbilical artery blood flow velocity waveforms were recorded by Doppler ultrasound in women with IUGR and PE.

RESULTS

By using immunostaining, we found a predominant expression of NDRG1 in the cytoplasm of villous trophoblasts. The expression of NDRG1 in samples from PE or IUGR was higher than control, with highest expression in PE. We confirmed these results by using immunoblotting and RT-qPCR. There was no correlation between the level of NDRG1 and umbilical artery blood flow.

CONCLUSION

The expression of NDRG1 is upregulated in placentas from pregnancies complicated by severe PE or IUGR. This finding likely reflects trophoblast response to hypoxic injury.

Placental 11beta-HSD2 activity, early postnatal clinical course, and adrenal function in extremely low birth weight infants

The placental enzyme 11beta-hydroxysteroid dehydrogenase-2 (11beta-HSD2) transforms maternal cortisol to inactive cortisone. Fetal glucocorticoid excess due to reduced 11beta-HSD2 activity could make small preterm infants susceptible to early adrenal insufficiency when the maternal cortisol source is no longer sustained. We assessed whether placental 11beta-HSD2 activity is related to early adrenal insufficiency and postnatal clinical course in extremely low birth weight (<1000 g) infants. Mean gestational age of the 44 infants was 26.6 wk (range, 23.7-32.0), birth weight was 747 g (440-981), and relative birth weight was -1.9 SD (-4.9 to 1.0). We determined placental 11beta-HSD2 activity, baseline, and ACTH-stimulated cortisol and assessed illness severity by the Score of Neonatal Acute Physiology (SNAP). One standard deviation decrease in placental 11beta-HSD2 activity corresponded to a 1.85 (95% CI 0.55 to 3.14; p = 0.006) unit increase in SNAP score and 2.9 mm Hg decrease in minimum mean arterial pressure (95% CI 0.3 to 5.6 mm Hg; p = 0.03). Placental 11beta-HSD2 activity was not associated with cortisol concentrations, although the confidence interval of the ACTH-stimulated cortisol was close to zero: 1 SD increase corresponded to 17% (-18% to 49%) increase in ACTH-stimulated cortisol. Moreover, a 1 SD decrease in enzyme activity was associated with a hazard ratio for postnatal glucocorticoid treatment of 1.63 (95% CI 1.00 to 2.65); p = 0.05. In ELBW infants, lower placental 11beta-HSD2 activity is associated with more severe early postnatal illness and hypotension. Although an association with baseline or ACTH-stimulated cortisol was not seen, possible relationships with other components of the hypothalamic-pituitary-adrenal axis remain to be determined.

Use of umbilical-cerebral Doppler ratios in predicting fetal growth restriction in near-term fetuses

OBJECTIVE

To compare the sensitivity and specificity of different umbilical-cerebral ratios in the prediction and detection of fetal growth restriction in near-term fetuses when the umbilical arterial waveform is within normal.

METHODS

A prospective cross-sectional observational study was carried out recruiting consecutive singleton pregnancies with clinically suspected fetal growth restriction after 34 weeks gestation. The umbilical-cerebral ratios were then calculated from the S/D, RI and PI values and correlated with immediate perinatal outcome.

RESULTS

A total of 187 patients were recruited. Twelve cases had abnormal UA Doppler flow velocity waveform studies. Of the 175 with normal UA Doppler findings, 92 (53.1%) were confirmed to have fetal growth restriction (FGR) with birth weights below the tenth centile for gestation. The detection rate of FGR by ultrasound biometry was 96.7%. The mean umbilical artery S/D, RI and PI values were higher in the fetal growth restriction group, while the middle cerebral artery values were lower as compared to fetuses with no growth restriction. A small but significant difference was seen in the umbilical-cerebral ratios of the different indices between the two groups. Receiver operator characteristic curves showed that there was little difference between the performances of the S/D, RI or PI ratios and all had limited power in predicting fetal growth restriction.

CONCLUSION

In the presence of normal umbilical artery Doppler waveforms, umbilical-cerebral ratios have limited power to predict fetal growth restriction.

Diagnosis and management of intrauterine growth restriction

The growth-restricted fetus is a fetus who fails to reach his growth potential and is at risk for perinatal morbidity and mortality. When a fetus has an estimated weight below the 10th percentile, in the absence of congenital anomalies and in the presence of a normal amount of amniotic fluid, Doppler velocimetry gives the most important information to differentiate the truly growth-restricted fetus from the fetus that is constitutionally small but otherwise normal. One area of debate and research is whether Doppler velocimetry can help in timing the delivery of the growth-restricted fetus. Data appear to support the use of ductus venosus velocimetry in deciding when to deliver, but randomized data on this point are still lacking.

Fetal Doppler velocimetry

The introduction of new techniques for evaluating fetal status, particularly fetuses at theoretical risk for hypoxic ischemic encephalopathy, requires the most rigorous evaluation before widespread clinical deployment. The considerations extend beyond clinical value to the significant medicolegal implications of a failure to predict or ascertain compromise. The attitudes to clinical Doppler velocimetry have been shaped to a large extent by these practical concerns and the initial skepticism, which is a necessary component of scientific rigor. Available data strongly indicate, however, that in competent hands umbilical artery Doppler im-proves the clinical management of IUGR pregnancies. Failure to use Doppler may have the undesirable effect of increasing the risk of adverse outcome in the growth-restricted fetus. There is also strong evidence of benefit in the management of the Rh isoimmunization. Although numerous other clinical applications are on the horizon, much more information is needed to determine objectively the benefits and risks of these newer applications.

Doppler blood flow in obstetrics

PURPOSE OF REVIEW

Our review on Doppler ultrasound in obstetrics aims to identify which vessels have a definite clinical role in obstetrics.

RECENT FINDINGS

The use of Doppler ultrasonography in the diagnosis and management of the intrauterine growth-restricted fetus improves the perinatal morbidity and mortality. However, the timing of delivery of the intrauterine growth-restricted fetus, based on Doppler ultrasonography, remains the subject of investigation. Robust data exist on the management of fetuses at risk for anemia because of red cell alloimmunization by using the middle cerebral artery peak systolic velocity. Appropriate training for the correct assessment of this vessel is fundamental. Doppler ultrasonography of the umbilical artery is useful in the counseling of patients with pregnancies complicated by twin-twin transfusion syndrome.

SUMMARY

Recently, Doppler ultrasonography has been shown to be helpful to the obstetricians in the diagnosis of the IUGR fetus, diagnosis of fetal anemia, twin-twin transfusion syndrome. These are the basis for timing the delivery of the IUGR fetus. However, more data are necessary. Doppler ultrasonography should be used to assess the fetal ductus arteriosus in patients treated with prostaglandin inhibitors. Doppler is also an important part of the fetal echocardiogram.

A transfer function-based mathematical model of the fetal-placental circulation

The circulation of a human fetus has been modeled using a transfer function that is based on the arterial dimensions at 28 weeks gestational age (GA). These dimensions have then been adapted for growth between 28 and 40 weeks GA. The input to the model is a series of current pulses at the fetal heart rate, where current in the model is analogous to volume blood flow in the fetus. The arterial system is divided into short segments that are cascaded together. The respective transfer functions are based on the dimensions, wall properties and fluid characteristics at each frequency and GA. Bleed off conductances distribute current to circuits representing the various anatomical regions. In particular, the placenta is simplified to a symmetrically distributed network of branching vessels, each represented by a transfer function. All calculations are performed in the frequency domain, after which the inverse Fourier transform is used to calculate the currents that represent the time-domain blood flow waveforms. Simulated flow waveform resistance index and pulsatility index values are within 8% of those reported for human clinical studies, at all gestational ages.

Endothelial cell apoptosis is induced by fetal plasma from pregnancy with umbilical placental vascular disease

OBJECTIVE

Vascular disease in the umbilical placental circulation that is detected by umbilical artery Doppler study is associated with adverse fetal outcome. Endothelial cell activation and platelet consumption are features of this pathologic condition. We postulated that this was due to the local release of factors that cause endothelial cell injury and that these would spill into the fetal circulation. To test this hypothesis, we examined for the presence in fetal plasma of factors that induced endothelial cell apoptosis in pregnancies that were complicated by umbilical placental vascular disease.

STUDY DESIGN

Isolated and cultured human umbilical vein endothelial cells were exposed to fetal plasma from the 3 fetal groups: normal pregnancy (n = 32 patients), pregnancy with umbilical placental vascular disease that was identified by an abnormal umbilical artery Doppler study (n = 38 patients), and pregnancy with maternal preeclampsia and normal umbilical artery Doppler study (n = 16 patients). Early apoptosis can be recognized by a loss of plasma membrane asymmetry with membrane uptake of annexin V. This was measured with annexin V and propidium iodide staining by fluorescent-activated cell scanning. Cells that underwent early apoptosis stained positive for annexin V and negative for propidium iodide (in contrast with cells that underwent necrosis). Cytosolic proteolytic activity was also measured. The lysates from endothelial cells that were stimulated by fetal plasma from umbilical placental vascular disease were tested for caspase-3 and caspase-8 activities by a fluorescent assay with spectrofluorophotometry.

RESULTS

The percentage of endothelial cells that underwent apoptosis was significantly higher (P <.05) when stimulated with fetal plasma from pregnancies with umbilical placental vascular disease (17.71% +/- 1.31%) than with fetal plasma from normal pregnancies (9.76% +/- 0.87%). In the presence of maternal preeclampsia with normal umbilical artery Doppler study, the percent of apoptotic cells (11.31% +/- 1.59%) was similar to that of the normal group. In the group with abnormal umbilical artery Doppler study, there was no difference between pregnancies with preeclampsia (n = 17 pregnancies) and without preeclampsia (n = 21 pregnancies). The protease activity of caspase-3 was significantly enhanced in the group with umbilical placental vascular disease compared with normal pregnancy (0.79 +/- 0.06 vs 0.45 +/- 0.08 microMol/L). However, no difference in caspase-8 activity was detected (0.66 +/- 0.05 vs 0.56 +/- 0.05 microMol/L).

CONCLUSION

Endothelial cell apoptosis is a feature of umbilical placental vascular disease. Our study demonstrates the presence of factors in the fetal plasma that caused endothelial cells to undergo early apoptosis. This increased apoptosis was only seen in the presence of placental vascular disease and was independent of the presence or absence of maternal preeclampsia. Our results indicate that programmed endothelial cell death occurs in the fetal circulation as a part of the injury that is associated with the development of umbilical placental vascular disease. The caspase-3, rather than caspase-8, signal transduction pathway appears to be involved in the mediation of endothelial cell apoptosis that was detected in our study.

Alterations of placental vascular function in asthmatic pregnancies

Asthma during pregnancy is associated with low-birthweight neonates at term but the mechanisms that cause this outcome are presently unknown. Changes in placental vascular function resulting from asthma or its treatment could contribute to altered fetal growth. We have prospectively followed women with asthma and a control group of women without asthma during their pregnancies, classified them based on asthma severity and glucocorticoid intake, and monitored fetal development and placental blood flow using Doppler ultrasound at 18 and 30 wk gestation. The placentae from these women were collected after delivery and vascular responses to dilator and constrictor agonists assessed using an in vitro placental perfusion method. At 18 wk gestation, umbilical artery flow velocity waveforms were significantly reduced in the moderate and severe asthmatic groups and in those women using high-dose inhaled glucocorticoid for the treatment of their asthma (ANOVA, p < 0.05). However, at 30 wk gestation there were no significant differences in umbilical artery flow velocity between control and asthmatic women (ANOVA, p > 0.05). Corticotropin-releasing hormone (CRH), a potent vasodilator that acts via the nitric oxide pathway, caused a dose-dependent vasodilatory response in all placentae in vitro. However, CRH-induced dilation was significantly reduced in moderate and severe asthmatics (ANOVA, p < 0.05). Vasoconstrictor responses to potassium chloride and prostaglandin F(2alpha) were reduced in placentae from moderate and severe asthmatic women (ANOVA, p < 0.05). These studies demonstrate significant differences in placental vascular function in pregnancies complicated by asthma, which may relate directly to the asthma or be a consequence of the associated glucocorticoid treatment. These changes in vascular function in asthmatic pregnancies may contribute to the low-birthweight outcome observed in this condition.

Utility of Doppler velocimetry in predicting outcome in twin reversed-arterial perfusion sequence

OBJECTIVE

The aim of this study was to describe Doppler velocimetric findings in pregnancies complicated by the twin reversed-arterial perfusion sequence and to determine the association of these findings with pregnancy outcome.

STUDY DESIGN

Six twin pregnancies complicated by twin reversed-arterial perfusion sequence had ultrasonographic and Doppler studies performed between 1990 and 1997. Pulsatile vessels in the umbilical cords of the pump and acardiac twins were insonated, and reversal of flow was confirmed in all cases. Resistive index values were calculated, and the difference in resistive index between the pump and acardiac twin in each pair was evaluated as a marker of pregnancy outcome.

RESULTS

Five of 6 pump twins survived the immediate neonatal period. Although 5 of the acardiac twins had abnormally elevated Doppler index values, no ratio of systolic to diastolic velocity or resistive index value of the acardiac twin alone was associated with either a good or poor prognosis for the pump twin. Among the 3 pump twins with good outcomes, all had a resistive index difference >0.20. Among the 3 pump twins with poor outcomes, all had small resistive index differences (<0.05).

CONCLUSION

We found larger differences in resistive index to be associated with improved outcome of the pump twin in pregnancies complicated by twin reversed-arterial perfusion sequence. Smaller resistive index differences were associated with poor outcome, including cardiac failure and central nervous system hypoperfusion.

The fetal cardiac isovolumetric contraction time in normal pregnancy and in pregnancy with placental vascular disease: the first clinical report using a new ultrasound technique

OBJECTIVE

To study the fetal cardiac isovolumetric contraction time in normal and complicated pregnancies with placental vascular disease using a newly developed digital Doppler cardiography system.

DESIGN

A preliminary case-control study.

SETTING

Tertiary referral hospital.

SAMPLE

One hundred and sixteen normal fetuses (20 to 40 weeks) and 55 complicated pregnancies with placental vascular disease as documented by a high systolic: diastolic ratio in the umbilical artery Doppler flow study.

METHOD

A digital Doppler cardiography system with a high sampling rate (4,000 Hz) was used to detect the fetal cardiac valvular movements. The isovolumetric contraction time was measured as the interval between the mitral valve closing and the aortic valve opening with a built-in scale device.

RESULTS

In normal pregnancy the isovolumetric contraction time remained remarkably constant with gestation and fetal heart rate. Comparison between clinical outcome and the isovolumetric contraction time of the complicated fetuses who were born within a week after the last determination of the isovolumetric contraction time revealed a strong correlation between prolonged isovolumetric contraction time duration and abnormalities in the perinatal course (non-reactive fetal heart rate pattern, low pulsatility index in the fetal middle cerebral artery Doppler flow and low birthweight infant).

CONCLUSIONS

The isovolumetric contraction time is constant with gestation and fetal heart rate in normal pregnancy. In the presence of placental vascular disease a prolonged fetal isovolumetric contraction time predicts adverse outcome.

Volumetric flow in the umbilical artery: normative data

OBJECTIVE

Provide normative data for the volumetric blood flow (cc/min and cc/min/kg) in the umbilical artery.

METHODS

Flow was determined from an umbilical artery in 252 normal obstetrical patients from 18-40 weeks' gestation utilizing pulsed Doppler and color flow Doppler with an angle of insonation of 30-60 degrees. Simultaneous velocimetry studies (S/D ratio, resistance and pulsatility indices), fetal biometry, and an anatomic survey were obtained to further define the normal population.

RESULTS

There was a steady increase in the flow (cc/min) in the umbilical artery as pregnancy progressed. Flow/kg showed a steady decline as fetal weight increased. Umbilical artery diameter increased until reaching a plateau at 32-34 weeks. Velocimetric results were consistent with known data.

CONCLUSIONS

Volumetric blood flow in the umbilical artery can be determined with relative ease and normative data from 18-40 weeks is presented for the first time.

Is an atherogenic lipoprotein profile in the fetus a prerequisite for placental vascular disease?

OBJECTIVE

To measure the blood apolipoprotein A-1 and apolipoprotein B in the fetal circulation in normal pregnancy and in pregnancy with evidence of vascular disease in the fetal umbilical placental circulation defined in the antenatal period by Doppler ultrasound study.

DESIGN

An observational study to compare fetal plasma apolipoprotein levels in normal and complicated pregnancy.

SETTING

A university hospital tertiary referral obstetric unit.

SAMPLES

Umbilical vein blood was collected at delivery from 22 normal fetuses delivered by elective caesarean section for non fetal reasons and 30 fetuses with evidence of umbilical placental vascular disease identified antenatally by Doppler ultrasound study.

METHODS

Plasma apolipoprotein A-1 and B were determined using an enzyme-linked immunosorbent assay (ELISA) methods.

MAIN OUTCOME MEASURES

Fetal plasma levels of apolipoprotein A-1 and B were measured.

RESULTS

There was a significantly lower level of fetal plasma apolipoprotein A-1 in placental insufficiency [placental insufficiency vs normal pregnancy, median 0.30 g/L (interquartile range 0.24, 0.39 g/L) vs 0.35 g/L (0.31, 0.42 g/L), P = 0.045]. In contrast, the levels of fetal plasma apolipoprotein B in placental insufficiency [0.20 g/L (0.17, 0.26 g/L)] were significantly increased compared with normal pregnancy [0.16 g/L (0. 14, 0.20 g/L), P = 0.03]. The ratio of fetal plasma apolipoprotein B to A-1 was also substantially higher in placental insufficiency [0.68 (0.55, 0.83)] than in normal pregnancy [0.45 (0.36, 0.60), P = 0.0003].

CONCLUSIONS

Our study has demonstrated that levels of fetal plasma apolipoprotein A-1, apolipoprotein B and the ratio of apolipoprotein B to A-1 were altered in the fetuses who are victims of umbilical placental insufficiency in the same direction as in adults associated with a high risk of atherogenesis.

Standards for the quantification of serial changes in Doppler resistance indices from the umbilical arteries

Two-hundred- and-seventy-four low-risk pregnancies underwent serial ultrasound examinations in order to determine the mean and standard deviation of the change in umbilical artery resistance indices with advancing gestation. There is an almost constant rate of reduction in the A/B ratio and the Pulsatility index over time from 28 weeks gestation until term. By calculating the standard deviation score of such changes, these reference ranges allow the change in the A/B ratio and Pulsatility index to be quantified. Such appropriately derived standards permits the further investigation of the evolution of abnormalities of feto-placental perfusion with regards to perinatal outcome.

Transdermal nicotine replacement in pregnancy: maternal pharmacokinetics and fetal effects

OBJECTIVE

Our purpose was to measure any short-term effects that the transdermal nicotine replacement system may have in pregnancy and to verify salivary nicotine and cotinine levels during patch placement.

STUDY DESIGN

After customary smoking cessation efforts had failed, six prenatal patients between 28 and 37 weeks' gestation who smoked between one and two packs per day were enrolled in this prospective study. The patients were admitted to the General Clinical Research Center for a period of 21 hours. During hospitalization we performed maternal and fetal assessments including vital signs, biophysical profile and electronic fetal monitoring, amniotic fluid index, and umbilical artery Doppler examinations. Salivary samples for cotinine and nicotine levels were collected at standard intervals.

RESULTS

There were no measurable differences in fetal or maternal well-being. During patch use salivary nicotine levels increased as expected, to a mean value of 19.0 +/- 13.5 micrograms/L at 480 minutes. Salivary cotinine concentrations remained low (approximately 50 micrograms/L) and varied little during the 480-minute period that the patch was worn. Overall, patients were satisfied with the transdermal patches.

CONCLUSION

There were no adverse maternal or fetal effects from the transdermal nicotine replacement system over the 6-hour period. Salivary nicotine concentrations were consistent with those seen in nonpregnant adults. Surprisingly, salivary cotinine concentrations were much lower than those seen in smoking nonpregnant adults.

Prenatal diagnosis of an infant with mosaic trisomy 16 of paternal origin

We present the first case of an infant with paternally-derived mosaic trisomy 16. Amniocentesis following an elevated maternal serum alpha-fetoprotein level and early fetal growth restriction at 19 weeks detected a high level of mosaicism with 25/33 colonies demonstrating trisomy 16 and 8/33 colonies with a normal 46,XX karyotype. Molecular studies revealed a paternal origin of the trisomy which was present in amniotic fluid cells, representing either a post-zygotic error or a meiosis II non-disjunction without crossing-over. In addition, there was normal biparental inheritance in the normal cell line. The symmetrically growth-restricted fetus was closely monitored for the remainder of the gestation. Decreased fetal movements at 36 weeks in conjunction with electronic fetal monitoring showing evidence of fetal distress necessitated abdominal delivery. Severe growth restriction, mild facial dysmorphism, and cardiac anomalies were identified. Microsatellite analysis demonstrated biparental inheritance in skin fibroblasts with a paternal origin for the trisomy in the placenta. Follow-up cytogenetic studies of additional tissues revealed 85 per cent trisomy 16 mosaicism in the placenta, yet only cytogenetically normal cells in lymphocytes and fibroblasts.

Pregnancy in a patient with homozygous familial hypercholesterolemia treated with long-term low-density lipoprotein apheresis

The pregnancy and delivery of a subject with homozygous familial hypercholesterolemia (FH) and coronary artery disease (CAD) were monitored closely for signs of maternal and fetal distress. Biweekly treatment with low-density lipoprotein (LDL) apheresis using dextran-sulfate cellulose columns was continued throughout the pregnancy, and lipid and lipoprotein levels were evaluated. During the course of the pregnancy and delivery, no signs of maternal coronary insufficiency developed. Serial ultrasonographic measurements of fetal growth indices and the blood flow velocity waveforms (FVWs) of the uterine and umbilical artery did not reveal any sign of fetal growth retardation or insufficiency of the uteroplacental circulation, respectively. During pregnancy, time-averaged concentrations of serum total cholesterol (TC), LDL cholesterol (LDL-C), apolipoprotein (apo) B, and lipoprotein(a) [Lp(a)] showed a gradual decline. Notwithstanding LDL apheresis, a gradual twofold increase of serum triglyceride (TG) levels was found. In the second and third trimester, high-density lipoprotein cholesterol (HDL-C) levels showed a 55% increase that coincided with a 75% reduction in hepatic lipase activity in postheparin plasma, normalizing after parturition. After delivery, lp(a) levels showed an almost twofold increase, which could not be explained by the interruption of LDL apheresis alone, and may be caused by changes in gonadal steroids. Histologic examination of the placenta and the umbilical arteries revealed no atherosclerotic changes, infarctions, or lipid deposits. In general, long-term LDL apheresis in homozygous FH can delay the onset and complications of severe CAD. In case of a pregnancy, LDL apheresis seems feasible and should be continued during the pregnancy to prevent superimposed hyperlipidemia and placental insufficiency.

The effect of acute volume expansion and vasodilatation with verapamil on uterine and umbilical artery Doppler indices in severe preeclampsia

Preeclampsia is associated with increased peripheral, uterine, and umbilical artery resistance. Acute blood pressure reduction may result in shunting of blood and sudden fetal distress. We therefore investigated the effects of volume expansion and verapamil therapy on uteroplacental and umbilical resistance during treatment of preeclampsia.

MATERIALS AND METHODS

Five severe preeclamptics underwent volume expansion and subsequent vasodilatation with an infusion of verapamil. Invasive hemodynamic monitoring and Doppler ultrasonography were used to study changes in maternal, uterine, and umbilical hemodynamics.

RESULTS

Volume expansion and subsequent verapamil therapy was associated with significant changes in maternal hemodynamics without significant change in uteroplacental or umbilical resistance. Uterine artery waveform changes were noted, with disappearance of notching in some cases.

CONCLUSIONS

Volume expansion and verapamil therapy effectively reduces maternal blood pressure in preeclampsia, without adversely affecting uteroplacental or umbilical artery resistance. Uterine artery waveform changes may be associated with improved fetal outcome.

The coagulation system in placental insufficiency: a study in the fetal circulation

OBJECTIVE

To examine the hypothesis that Doppler-defined umbilical placental insufficiency is associated with intravascular coagulation in the fetal circulation.

DESIGN

A prospective, descriptive, single centre study.

SETTING

The University of Sydney, Department of Obstetrics at Westmead Hospital.

SUBJECTS

Ninety-one infants were classified on the basis of the systolic:diastolic (SD) ratio of the umbilical artery flow velocity waveforms into severe (SD > 99.9th centile), moderate (SD > 95th centile) or control groups.

INTERVENTION

Blood was collected from the umbilical vein at delivery.

MAIN OUTCOME MEASURES

The coagulation variables measured were the plasma concentrations of thrombin-antithrombin, fibrinopeptide A and fibrinogen, the antithrombin III activity, the prothrombin time and the activated partial thromboplastin time.

RESULTS

There were no differences in activated partial thromboplastin time, antithrombin III activity, fibrinopeptide A or thrombin-antithrombin complex concentrations between fetuses with placental insufficiency and those with no placental disease. Fetuses with severe and moderate placental insufficiency had a statistically significant prolongation of their mean prothrombin time compared to controls (23.7 +/- 0.8, 23.6 +/- 1.6, and 19.9 +/- 0.6 s, respectively). Infants in the severe group had a lower plasma fibrinogen concentration than control fetuses (1.66 +/- 0.09 and 1.94 +/- 0.09 g/l, respectively). The activated partial thromboplastin time and antithrombin III activity were both highly dependent on gestational age.

CONCLUSIONS

These results do not support the hypothesis that Doppler-defined umbilical placental insufficiency is associated with activation of coagulation in the fetal circulation.

Erythrocytes in fetuses with abnormal umbilical artery flow velocity waveforms

OBJECTIVE

Our purpose was to measure erythrocyte indexes in fetuses with two grades of Doppler-defined umbilical placental insufficiency.

STUDY DESIGN

A prospective study comprising 110 infants categorized into control, moderate, and severe groups by umbilical artery waveform studies was undertaken at the University of Sydney at Westmead Hospital. Fetal erythrocyte indexes were measured in umbilical venous blood. Multivariate analyses of variance with post hoc Bonferroni t tests were used in the statistical analysis.

RESULTS

The erythrocyte count, hematocrit, and hemoglobin concentration were all significantly higher (p < 0.001) in the two placental insufficiency groups than in the controls. Both placental insufficiency groups were affected to the same extent.

CONCLUSIONS

Differences exist in the erythrocyte populations of fetuses with Doppler-defined placental insufficiency compared with controls. Importantly, these differences occur in more than just the most severe cases. These changes may represent a compensatory response to the placental vascular lesion detected by abnormal umbilical artery waveforms.

Doppler velocimetry in pregnancy

Since the late 1970s, Doppler velocimetry has been investigated extensively for use in obstetrics. Initially, this technique showed promise for the management of certain complications of pregnancy; this promise has yet to be fulfilled. Doppler velocimetry of either the uterine or umbilical vessels, which showed some merit in selecting growth-retarded fetuses at particular risk, has neither become a screening tool for intrauterine growth retardation nor proven clinically successful in improving fetal outcome. Likewise, its use for other complications of pregnancy (eg, postdate pregnancy, twin pregnancy, and diabetes) has not led to improved pregnancy outcome. More recently this technique has been used to study other vascular beds. Changes in the Doppler characteristics of these vascular beds may demonstrate the fetal response to its environment. These investigations provide the potential for a better understanding of fetal physiology; however, it has yet to be shown by prospective evaluation that their application results in improved pregnancy outcome. This review defines the uses and limitations of Doppler ultrasound in current obstetric practice.

Antenatal tests of fetal welfare and development at age 2 years

OBJECTIVE

Our objective was to examine the outcomes at 2 years of age of fetuses delivered electively before 34 weeks, studied antenatally with two tests of fetal well-being.

STUDY DESIGN

Forty-two fetuses from high-risk pregnancies delivered electively by cesarean section before 34 weeks were stratified into normal versus abnormal subgroups with umbilical Doppler flow velocity waveform and fetal heart rate results. Developmental outcome was assessed at 2 years. Two comparison groups were also selected: 40 matched premature controls delivered spontaneously before 34 weeks and 67 normal babies delivered spontaneously at term. Frequency outcome data were tested with chi 2 analyses and the remainder with analyses of variance.

RESULTS

Within the electively delivered study group poor cognitive progress at 2 years was more strongly associated with an abnormal fetal heart rate result than an abnormal Doppler result. Compared with the premature control and normal term groups, electively delivered fetuses were significantly delayed in growth, cognition, and motor development (p < 0.005).

CONCLUSIONS

Adverse fetal welfare in a high-risk obstetric sample was associated with poorer outcome at 2 years. However, the whole of the group of fetuses from such high-risk pregnancies showed significant developmental delay compared with normal term children and, more importantly, matched premature infants delivered spontaneously from otherwise uncomplicated pregnancies.

Doppler velocimetry in twin pregnancy

The flow velocity waveform profile in the umbilical artery was measured in 50 pairs of twins during the last week before birth. A significant association was found between high resistance indicies and occurrence of late fetal heart rate decelerations; the higher the resistance, the more frequent the decelerations. Further, the connection between high resistance in the circulation of the umbilical artery and low birth weight was confirmed. Flow velocity measurements in the umbilical artery seem to be a valuable tool in identifying twin fetuses suffering from placental insufficiency.

Doppler flow velocity waveform analysis in high risk pregnancies: a randomized controlled trial

OBJECTIVE

To test whether the introduction of Doppler waveform analysis into the ultrasound department of a tertiary level hospital reduces neonatal morbidity and improves obstetric management.

DESIGN

A randomized controlled trial.

SETTING

Department of Ultrasound, King Edward Memorial Hospital, Perth, Western Australia.

SUBJECTS

505 women with pregnancy abnormalities referred to an ultrasound department for fetal investigation during the third trimester.

INTERVENTION

Continuous wave Doppler studies of umbilical and uteroplacental arterial circulations. Results were revealed to patients and clinicians.

MAIN OUTCOME MEASURES

Principal end point was the duration of neonatal stay in hospital; other end points included the number and type of fetal heart rate monitoring studies, obstetric interventions, frequency of fetal distress, birthweight, Apgar scores and need for neonatal intensive care.

RESULTS

There was no effect on the duration of neonatal stay in hospital. Small trends in obstetric management were observed with study group patients having fewer contraction stress tests, less likelihood of antepartum fetal distress, and more likelihood of fetal distress after induction of labour leading to emergency caesarean section. Depressed Apgar scores were more frequent in the study group.

CONCLUSION

Introduction of Doppler waveform studies did not result in reduced neonatal morbidity but did have a small effect on obstetric management. For each institution the role of Doppler studies in late pregnancy will be influenced by the usage of other tests of fetal welfare already entrenched in clinical practice.

Maternal angiotensin sensitivity and fetal Doppler umbilical artery flow waveforms

The angiotensin pressor response was investigated in normotensive pregnancies which had umbilical Doppler flow velocity waveforms suggestive of placental vascular disease. Of the 36 pregnancies studied at between 24 and 38 weeks gestation, 18 had a positive response to the angiotensin pressor test, these women were delivered earlier (35.3 vs 38.5 weeks, P = 0.015), had a lower mean birthweight centile (14 vs 36, P less than 0.001) and higher frequency of fetal distress in labour (40% vs 7%, P = 0.06) when compared with the 18 women who had a negative response. The Doppler umbilical systolic-diastolic (S-D) ratio decreased with gestation in the negative group, suggesting continuing placental growth and vascular expansion, whereas the S-D ratio increased in the positive group (P less than 0.001), indicative of vascular obliteration. We suggest that the positive angiotensin pressor response is primarily associated with the placental vascular pathology. Angiotensin infusion had no acute effect on maternal uteroplacental or fetal umbilical artery flow velocity waveforms.

Fetal umbilical artery velocity waveforms and subsequent neonatal outcome

Flow velocity waveforms (FVWs) from the fetal umbilical artery were recorded from 2178 pregnant women over a 6-year period. All of them had an obstetric factor indicating increased risk of fetal compromise. A total of 6749 studies was recorded. The systolic diastolic (AB) ratio was measured and classified as normal (less than 95th centile), elevated (95-99th centile), high (greater than 99th centile) or extreme (absent diastolic flow). The results of these studies have been related to subsequent fetal and neonatal outcome. An abnormal umbilical artery FVW was associated with shorter gestation and infants with lower birthweight, shorter length and lower ponderal index. There was a highly significant association between an abnormal FVW and the birth of an infant small for gestational age. The significance of the association increased with the increased abnormality of the umbilical artery FVW and this was independent of gestational age. Preterm infants associated with high or extreme AB ratios spent twice as long in the neonatal nursery than those with normal AB ratios. Analysis of 794 pregnancies studies serially indicated that an abnormal FVW in which the AB ratio was increasing, in contrast to a decreasing AB ratio, predicted a poor outcome for both size at birth and duration of neonatal intensive care. We conclude that in high risk pregnancy Doppler umbilical artery FVW studies predict the most compromised fetuses in terms of growth retardation and requirements for neonatal intensive care.

The current status of maternal and fetal blood flow velocimetry

Significant progress has been achieved in regard to normative data for uteroplacental and fetal blood flow velocity and the factors which may affect these observations. Associations have been demonstrated between abnormal indices of maternal and fetal blood flow velocity and pregnancy-induced hypertension, fetal growth retardation, fetal blood gas measures, and intrapartum clinical fetal distress. However, in general, the predictive power is modest and no evidence has yet been provided to indicate that these measures can be used as a screening test in the general obstetric population. Continuing research is highly desirable. At the present time, the use of Doppler assessment of blood flow in pregnancy should be limited to the investigational setting.

Doppler velocimetry: critical analysis of umbilical, cerebral and aortic reference values

Cross-sectional reference standards of the umbilical flow velocity waveforms were investigated from 18 to 38 weeks of gestation on 482 normal pregnancies. A significant decrease in the pulsatility index (PI) and systolic/diastolic (SD) ratio was observed during gestation. This phenomenon was confirmed in a longitudinal study on 150 patients of the same population. The two slopes of cross-sectional and longitudinal data were not significantly different. A bimodal distribution of PI and S/D ratio was observed. Six per cent of data fell above the vast majority of cases. The dimension of the population studied allowed us to consider these findings not as outliers but as an interesting transient phenomenon of very low end-diastolic velocities which can occur in normal fetuses, without concomitant variations on the thoracic aorta and middle cerebral artery. Cross-sectional reference ranges were studied for these vessels on the same population from 26 to 38 weeks of gestation. A significant decrease in the PI of the middle cerebral artery was observed versus a significant increase in the PI of the thoracic aorta. These latter indices could be used to obtain indirect information on the normal redistribution of blood flow in the human fetus in the third trimester of gestation. However, the great variability observed should warn against the risks of a simplistic clinical use of these observations.

Doppler umbilical artery velocimetry in pregnancies complicated by intrahepatic cholestasis

Doppler umbilical velocimetry is a useful clinical tool for antepartum fetal surveillance of pregnancies at risk of fetal compromise. Intrahepatic cholestasis of pregnancy is associated with an increased incidence of fetal death, which might due to the toxic effect of elevated maternal serum concentrations of bile acids. To study a possible effect of the concentration of bile acids on the umbilical circulation we performed pulse-wave Doppler velocimetry of the umbilical artery in 15 patients with intrahepatic cholestasis between 34 and 38 weeks of gestation. The findings were compared to the Doppler flow velocities of the umbilical artery of 129 normal pregnancies. Peak-systolic (A) and end-diastolic (B) velocities of two to three cardiac cycles were measured by electronic calipers and the Pourcelot (PR)-index (PR = (A - B)(A)) was calculated. Two of 29 Doppler measurements in patients with intrahepatic cholestasis were above two standard deviations (2 SD) of the values in normal pregnancies. No significant correlation was found between Doppler flow velocities and serum levels of bile acids (r = 0.20) or the levels of alanine aminotransferase (ALAT) (r = -0.05). The mean level of bile acids was 24 mumol/l with a maximum of 98 mumol/l. The mean level of ALAT was 165 IU/l with a maximum of 576 IU/l. Since even high levels of bile acids do not influence umbilical circulation, Doppler investigations of the umbilical artery seem to be of little value in studying the disease-specific risk of fetal compromise in pregnancies complicated by intrahepatic cholestasis.

Parameters and standardization in obstetric Doppler

Obstetric Doppler is still largely empirically based, although possible clinical applications are already under examination. This article examines some of the basic instrumentation and hemodynamic issues--which physiological parameters would we ideally like to assess, and what can we do in practice with current Doppler instrumentation? It is shown that the rate of blood flow and the flow resistance are two of the most basic hemodynamic parameters. It is possible to estimate the flow rate with (specialized) Doppler equipment, but there is no method available at present to measure the flow resistance. Analysis of the blood velocity waveform provides some information concerning flow resistance, as long as it can be assumed that other factors that might affect the waveform have not deviated significantly from the norm. Practical considerations in choosing the instrumentation and designing the examination protocol are discussed, and issues of quality control are emphasized.

The diagnostic efficacy of the umbilical arterial systolic/diastolic ratio as a screening tool: a prospective blinded study

This prospective blinded study investigated the diagnostic efficacy of the umbilical arterial systolic/diastolic ratio performed at 34 to 36 weeks' gestation for identifying pregnancies at a high risk for adverse perinatal outcomes. A series of 350 consecutive singleton pregnancies were included in the study. A continuous-wave Doppler instrument with a 4 MHz transducer was used. The criteria for an abnormal perinatal outcome included intrauterine growth retardation, an Apgar score of less than 7 at 5 minutes, umbilical arterial pH at birth less than 7.20, presence of thick meconium, fetal distress in labor, and neonatal complications necessitating admission to the neonatal intensive care nursery. The analytic techniques included determination of the receiver operating characteristic curve, sensitivity, specificity, positive and negative predictive values, and the kappa index. The results demonstrated that although the cutoff value of 2.9 showed the maximum inherent discriminatory power, its diagnostic efficacy (sensitivity, 0.83; specificity, 0.87 positive predictive value, 0.74; negative predictive value, 0.92; and kappa index, 0.68) was not substantially different from that of the more common cutoff value of 3.0 (sensitivity, 0.79; specificity, 0.93; positive predictive value, 0.83; negative predictive value, 0.91; and kappa index, 0.73). Both values were rated good to excellent by the kappa index. The study also demonstrated that the systolic/diastolic ratio was a better predictor of general abnormal outcome than of the suboptimal fetal growth.

Doppler umbilical and uterine flow waveforms in severe pregnancy hypertension

Doppler studies of the umbilical and uteroplacental bed arterial flow velocity waveforms were performed in a series of women suffering from severe proteinuric pregnancy hypertension. Ninety-five women were studied and the mean interval between the last study and delivery was 1.4 days. An abnormally elevated umbilical artery systolic:diastolic (AB) ratio was present in 61 (64%) of the women. All 10 perinatal deaths were associated with pregnancies with an abnormal umbilical artery AB ratio. An elevated umbilical artery AB ratio was significantly associated with small-for-gestation and neonatal morbidity. Infants associated with extremely high umbilical artery AB ratios (greater than or equal to 99th centile) spent twice as long in the neonatal nursery as those with a lower value. There was no relation between the duration of hypertension and the umbilical study result. The uteroplacental bed artery flow velocity waveform did not correlate with fetal or neonatal mortality or morbidity. Patients with abnormal uteroplacental AB ratios also had abnormal umbilical artery AB ratios. We conclude that an abnormal fetal umbilical artery Doppler flow velocity waveform correlates with adverse fetal outcome in severe proteinuric pregnancy hypertension and suggest that the associated placental lesion may precede the maternal hypertension.

Direct determination of the ovine fetal umbilical artery blood flow waveform

Ultrasonographic umbilical artery blood flow velocity waveform analysis has been proposed as a means of noninvasive assessment of fetal well-being. We computed waveform indices from directly measured umbilical artery blood flow in chronically instrumented ovine fetuses from 109 to 138 days of gestation (term, 145 days). The three waveform indices (systolic/diastolic ratio, pulsatility index, and resistance index) correlated significantly with each other (r = 0.90 to 0.98). These indices progressively decreased with gestation and were significantly correlated with calculated umbilical vascular resistance (r = 0.68 to 0.70, p less than 0.01) and with umbilical blood flow (r = -0.71, p less than 0.01). During the final week of pregnancy, systolic/diastolic ratio could be predicted by the combination of placental size (total cotyledonary mass), fetal size (ponderal index), and either umbilical blood flow or umbilical vascular resistance (multiple linear regression, r2 = 0.94). Fetal heart rate declined from day 109 of gestation to 138 days. Fetal heart rate was significantly correlated with waveform indices only when values exceeded 170 beats/min (r = -0.37 to -0.51). Ovine fetal umbilical artery waveform indices changed at approximately the same rate as those reported for human fetuses in late gestation on the basis of external Doppler ultrasonographic velocity measurements. These results suggest that the sheep is a suitable model for investigations of umbilical artery waveform analysis.

Continuous wave Doppler flow velocity waveforms from the umbilical artery in normal pregnancy

The objective was to establish a normal reference range of the indices of umbilical artery waveforms using continuous wave doppler ultrasound. A prospective longitudinal study was made of 85 uncomplicated singleton pregnancies between 16 and 40 weeks gestation (783 recordings). Pulsatility Index (P.I.), Resistance Index (R.I.) and A/B ratio were measured at each visit. The mothers all delivered normal healthy infants weighing more than the 10th centile for gestational age. All three indices have a positively skewed frequency distribution, a factor not generally appreciated until recently and the ranges are therefore described using non-parametric statistics. Placental resistance decreases as term approaches, the 50% PI at 16 weeks was 2.06, at 32 weeks was 1.08 and at 40 weeks was 0.85. The results show a comprehensive reference of normal values and provides a sound basis for the further study of abnormal pregnancy. It represents the largest published study of its type using continuous wave Doppler.

Intrapartum Doppler velocimetry, amniotic fluid volume, and fetal heart rate as predictors of subsequent fetal distress. I. An initial report

This study examines the usefulness of umbilical artery Doppler velocimetry, amniotic fluid volume assessment, and fetal heart rate data in the early intrapartum period as predictors of subsequent fetal distress. A total of 109 patients seen in the latent phase of labor in the labor and delivery area were studied. Both an abnormal initial fetal heart rate and an amniotic fluid index less than or equal to 5.0 cm were associated with a significant increase in the incidence of intrapartum fetal distress. Conversely, a systolic/diastolic ratio greater than 3.0 by Doppler ultrasonography was not associated with increased fetal morbidity. Overall, the sensitivities, specificities, and positive predictive values of the fetal heart rate tracing and the amniotic fluid volume assessment were comparable. Doppler systolic/diastolic ratios showed very poor sensitivity and positive predictive value. We conclude that the fetal heart rate tracing or the assessment of amniotic fluid volume in the early intrapartum period are reasonable predictors of subsequent fetal condition. The lack of patients with the absence of or reverse umbilical velocity preclude conclusions with regard to Doppler systolic/diastolic ratios for this purpose.

Doppler umbilical artery waveform indices--normal values from fourteen to forty-two weeks

Normal values for Doppler waveform indices of the umbilical artery have been reported for gestational ages of 20 to 40 weeks in small numbers of normal patients. We evaluated 590 patients studies performed at 2-week intervals from 14 to 42 weeks' gestation on patients without medical or pregnancy complications. Readings were obtained during fetal quiet times (no fetal breathing or movements). Values for A (systolic) and B (diastolic) pressures were plotted as Pourcelot (A - B/A) and A/B ratios. Mean, SD, and 95% confidence limits were derived, and the skewness, kurtosis, and regression correlations were calculated. No diastolic flow was found in any pregnancy greater than 15 weeks' gestation (n = 25) or in 50% of the gestations between 15 to 17 weeks (n = 25). When diastolic pressure equals zero, the Pourcelot ratio value equals one and the A/B ratio approaches infinity and loses meaning. Recent work by Thompson et al. suggests that the Pourcelot ratio fits a normal distribution from 20 to 40 weeks' gestation and that the A/B ratio (which does not fit a normal curve) may be transformed to a normal distribution by conversion of the A/B ratio to 1/1 - Pourcelot ratio. Our data supports the normality of both indices from 18 to 42 weeks' gestation, but these assumptions are not applicable as the Pourcelot ratio approaches one or as the A/B ratio approaches infinity. Knowledge of normal umbilical flow ratios at gestational ages from 18 weeks may allow early detection and directed management of high-risk pregnancies.

Low-dose aspirin therapy improves fetal weight in umbilical placental insufficiency

A randomized, placebo-controlled, double-blind trial was carried out to evaluate the fetal benefits of low-dose aspirin (150 mg/day) as a treatment of placental insufficiency during the last trimester of pregnancy. Forty-six women referred for study because there was concern about fetal welfare were found to have an elevated umbilical artery wave form systolic/diastolic ratio. Mothers with severe hypertension were excluded because fetal condition would not necessarily be the dominant determinant of obstetric decision making. A distinction was made between a high systolic/diastolic ratio (greater than 95th but less than 99.95th percentile) and an extreme systolic/diastolic ratio (greater than 99.95th percentile). There were 34 patients in the high ratio group and 12 in the extreme group. Aspirin therapy was associated with an increase in birth weight (mean difference 526 gm [p less than 0.02]), head circumference (1.7 cm [p less than 0.025]), and placental weight (136 gm [p less than 0.02]) in those patients with a high initial umbilical artery systolic/diastolic ratio. For the 12 women with an extreme initial systolic/diastolic ratio, aspirin therapy did not result in a significantly different pregnancy outcome.

Doppler ultrasound waveform indices: A/B ratio, pulsatility index and Pourcelot ratio

Three different indices, the A/B ratio, the pulsatility index (PI) and the Pourcelot ratio (PR), are in common use for quantitative analysis of umbilical artery Doppler ultrasound waveforms. A detailed examination of the similarities and differences between these indices, together with the expected errors for each, was undertaken to enable informed comparisons and choices to be made. The indices were calculated from 133 last trimester recordings using an objective and very reliable computer analysis technique. The PI is more difficult to calculate than the other two quantities and the extra computation does not provide any extra information. The A/B ratio appears the simplest index to use but the values are not normally distributed. With the PR a normal distribution of values can be assumed. A theoretical consideration of errors showed that none of the indices is intrinsically less error prone for last trimester waveforms overall. The errors in the A/B ratio increase as the value of the index increase, whereas the converse holds for the PI and PR.